Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listDiphemanil Methylsulfate

Diphemanil Methylsulfate

  • CAS NO.:62-97-5
  • Empirical Formula: C20H24N.CH3O4S
  • Molecular Weight: 389.51
  • MDL number: MFCD00865157
  • EINECS: 200-552-4
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-11-19 20:33:22
Diphemanil Methylsulfate Structural

What is Diphemanil Methylsulfate?

Description

Diphemanil is a quaternary ammonium anticholinergic agent. It induces relaxation of isolated guinea pig trachea strips precontracted with methacholine (EC50 = 0.12 nM). Diphemanil reverses increases in lung resistance and decreases in dynamic lung compliance induced by the non-selective acetylcholine receptor agonist carbachol (carbamoylcholine; ) in vagotomized cats (ED50s = 17.5 and 19.3 μg/kg, respectively). It reduces salivation induced by the muscarinic acetylcholine receptor agonist pilocarpine in mice when administered subcutaneously at doses ranging from 1.25 to 10 mg/kg.

Originator

Pranta,Schering,US,1952

The Uses of Diphemanil Methylsulfate

Bronchodilatator;Anticholinergic

The Uses of Diphemanil Methylsulfate

Diphemanil Methosulfate is an anticholinergic agent; a synthetic quaternary ammonium compound with anitmuscarinic properties used in the treatment of Frey''s syndrome and is used as a parasympatholytic bronchodilator agent.

Definition

ChEBI: The alkene resulting from the formal Wittig olefination of benzophenone and 1,1-dimethyl-4-bromopiperidinium methylsulfate. A quaternary ammonium anticholinergic, it binds muscarinic acetycholine receptors and thereby decreases secretory excretion of stoma h acids, saliva and sweat, It is used topically in the treatment of hyperhidorsis (excessive sweating).

Manufacturing Process

(A) Preparation of diphenyl-(N-Methyl-4-Piperidyl)carbinol: to a Grignard solution prepared from 4.9 grams of magnesium, 100 cc of ether and 31.4 grams of dry
omobenzene is added 18.5 grams of 4-benzoyl-Nmethylpiperidine in 200 cc of dry ether. The reaction mixture is heated with stirring for 4 hours on the steam bath and then decomposed. The organic layer is separated and the aqueous layer extracted with benzene. The combined organic extracts are concentrated and the residue, diphenyl-(Nmethyl-4-piperidyl)carbinol, recrystallized from benzene-petroleum ether, MP 130-131°C. The Grignard complex may also be decomposed with ice and hydrochloric acid and the insoluble hydrochloride of the carbinol isolated directly.
(B) Preparation of diphenyl-(N-Methyl-4-Piperidylidene)methane: the carbinol can be dehydrated with 60% sulfuric acid. In general, to one part of the carbinol there is added 10 parts of 60% sulfuric acid. The mixture after heating for 6 hours is poured onto cracked ice, the solution made alkaline with dilute sodium hydroxide and the oily basic layer extracted with ether. The ether extracts after washing with water are dried over sodium sulfate, and after removing the ether, the residue is distilled in vacuo, MP 52°-53°C.
(C) Preparation of Final Product: The product from (B) is reacted with dimethyl sulfate in benzene to give the final product, MP 196°-197°C.

brand name

Prantal (Schering).

Therapeutic Function

Spasmolytic

General Description

Diphemanil methylsulfate,4-(diphenylmethylene)-1,1-dimethylpiperidiniummethylsulfate (Prantal), or diphemanil methylsulfate is apotent cholinergic blocking agent. In the usual dosagerange, it acts as an effective parasympatholytic by blockingnerve impulses at the parasympathetic ganglia, but it doesnot invoke a sympathetic ganglionic blockade. It is claimedto be highly specific in its action on those innervations thatactivate gastric secretion and GI motility. Although thisdrug can produce atropine-like side effects, they rarelyoccur at recommended doses. The highly specific nature ofits action on gastric functions makes the drug useful inthe treatment of peptic ulcer, and its lack of atropine-likeeffects makes its use much less distressing than other antispasmodicdrugs. In addition to its action in decreasinggastric hypermotility, diphemanil methylsulfate is valuablein hyperhidrosis in low doses (50 mg twice daily) or topically.The drug is not well absorbed from the GI tract,particularly in the presence of food, and should be administeredbetween meals. The methylsulfate salt was chosen asthe best, because the chloride is hygroscopic and the bromideand iodide ions have exhibited toxic manifestations inclinical use.

Properties of Diphemanil Methylsulfate

Melting point: 194-195℃
storage temp.  Inert atmosphere,Store in freezer, under -20°C
Water Solubility  Soluble in water
solubility  : 16.67 mg/mL (42.80 mM; Need ultrasonic)
form  powder to crystal
color  White to Almost white
Stability: Hygroscopic

Safety information for Diphemanil Methylsulfate

Signal word Warning
Pictogram(s)
ghs
Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H302:Acute toxicity,oral
H315:Skin corrosion/irritation
H319:Serious eye damage/eye irritation
Precautionary Statement Codes P264:Wash hands thoroughly after handling.
P264:Wash skin thouroughly after handling.
P270:Do not eat, drink or smoke when using this product.
P280:Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352:IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P332+P313:IF SKIN irritation occurs: Get medical advice/attention.
P337+P313:IF eye irritation persists: Get medical advice/attention.

Computed Descriptors for Diphemanil Methylsulfate

Related products of tetrahydrofuran

You may like

  • Diphemanil Methylsulfate CAS 62-97-5
    Diphemanil Methylsulfate CAS 62-97-5
    62-97-5
    View Details
  • 56-10-0 2-(2-Aminoethyl)isothiourea dihydrobromide, 98%+
    56-10-0 2-(2-Aminoethyl)isothiourea dihydrobromide, 98%+
    56-10-0
    View Details
  • 2-Ethyl-4-methyl-1-pentanol 106-67-2 98%+
    2-Ethyl-4-methyl-1-pentanol 106-67-2 98%+
    106-67-2
    View Details
  • 0/3/98 5-Aminoimidazole-4-Carbonitrile 98%+
    0/3/98 5-Aminoimidazole-4-Carbonitrile 98%+
    0/3/98
    View Details
  • 4-chloro-3,5-dinitropyridine 98%+
    4-chloro-3,5-dinitropyridine 98%+
    View Details
  • 1-(4-chlorophenyl)propan-1-one 98%+
    1-(4-chlorophenyl)propan-1-one 98%+
    View Details
  • 93465-26-0 2'-Methoxy-biphenyl-2-carboxaldehyde 98%+
    93465-26-0 2'-Methoxy-biphenyl-2-carboxaldehyde 98%+
    93465-26-0
    View Details
  • 602-00-6 3-hydroxy-2-nitrobenzoic acid 98%+
    602-00-6 3-hydroxy-2-nitrobenzoic acid 98%+
    602-00-6
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.